Company intelligence / Profile preview

Astellas Pharma Global Development, Inc.

Northbrook, Illinois, United States

Ownership: Private
Employees: ~15000
Development stage: Other

Overview

Astellas has a broad commercial portfolio (oncology, urology, transplantation, nephrology) and 19 R&D projects targeting priority and non-communicable diseases; 6 programs are in late-stage development including access-focused global health initiatives

Therapeutic areas: NephrologyMen's HealthInfectious DiseasesOncologyNeurology
Modalities: Small moleculeBiologicMonoclonal antibodyAntibody-drug conjugateGene therapyCell therapy
Industry: Pharma

Drug pipeline

11 assets

ASP0113

10 more assets in the full pipeline.

Request access →

Partnerships

Cytokinetics (skeletal muscle diseases)Pediatric Praziquantel Consortium (schistosomiasis)Mitsubishi Research Institute (Japan pharma startup collaboration)

Beyond the preview

Go deeper on Astellas Pharma Global Development, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astellas Pharma Global Development, Inc..

Explore the full profile